Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Pain Management in Veterinary Practice provides veterinary practitioners with the information needed to recognize and manage pain in a wide range of large, small, and exotic animal species. Pain Management in Veterinary Practice offers specific strategies for addressing pain in animals, including local and regional analgesia, continuous rate infusions and novel methods of analgesic drug delivery. Acute surgical, traumatic, and disease-related pain is generally treated with one or more analgesic, or pain-relieving drugs. Selection of the most suitable drug or drug combination is based on the anticipated severity of pain, the pet’s overall health and the specific drugs helpful for the species. For more extensive injuries or disease-related tissue damage, analgesics from more than one drug class are often prescribed. In addition, veterinary pain management has accurately and figuratively empowered the veterinarian to look inside the patient, assist therapy and allowed follow up. Hence, keeping up with advancement in technology and veterinarian necessities, the veterinary pain management market is expected to propel in future.
The veterinary pain management market has gained significant growth due to increase in companion animal adoption and growth in the number of veterinary practitioners & their income levels in developed economies are some of the major factors contributing to the growth of the veterinary pain management market. Also, Growing prevalence of animal diseases causing pain and inflammation will also contribute to the growth of the veterinary pain management market in the coming years. However, growing pet care expenditures is one of the major factor hampering the global market growth.
The veterinary pain management market is segmented by product, application, animal type, distribution channel and geography
On the basis of product, the veterinary pain management market is segmented into drugs and devices. The drugs segment is bifurcated into type and route of administration. Furthermore, type segment is classified into NSAIDS, opioids, local anesthetics, alpha-2 agonists, disease-modifying osteoarthritis drugs (DMOADS) and other drugs. Likewise, the route of administration is segmented into oral, parenteral and topical. Moreover, the devices segment is categorized into laser therapy devices and electromagnetic therapy devices.
Various procedures were studied in the report such as a companion animals and livestock. Among these, the companion animals segment is classified into dogs, cats and horses and other companion animals. Furthermore, livestock segment is bifurcated into cattle, swine and other livestock. The companion animals segment accounted for the largest market share, owing to the increasing companion animal ownership, rising awareness about animal health among pet owners and increasing pet healthcare expenditure.
Based on application, the veterinary pain management market is segmented into joint pain, postoperative pain, cancer, others (traumatic pain, abdominal pain, neuropathic pain, dermatological pain, mastitis etc.). The joint pain segment is classified into osteoarthritis and musculoskeletal disorders. The joint pain application on high demand in veterinary pain management market owing to the rising pet population, increasing prevalence of musculoskeletal disorders.
On the basis of end user, the veterinary pain management market is segmented into veterinary hospitals & clinics, research institutes and universities and laboratories. The hospitals & clinics segment has significant share in the veterinary pain management market and is also estimated to dominate the market during the forecast period 2020 to 2025. Increasing number of hospitals, growing veterinary expenditure and combination treatments are key factors boosting the hospitals segment.
By geography, the veterinary pain management market is studied across the countries of key regions such as, North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America accounted for the largest market share in 2018, followed by Asia-Pacific. Growing animal healthcare expenditure, large number of hospitals & clinics, growing pool of veterinarians, and high prevalence of diseases causing pain in the region. However, the Asia-Pacific region is projected to grow at a fastest CAGR during the forecast period, due to advancement in health care services in veterinary pain management.
Some of the major players operating in the global veterinary pain management market includes Boehringer Ingelheim, Zoetis, Elanco, Merck Animal Health, Henry Schein, Bayer, Vetoquinol, cannpal animal therapeutics ltd, Norbrook Laboratories, Ceva Santé Animale, Dechra Pharmaceuticals, Chanelle, K-Laser USA and Assisi Animal Health. Market players are involved in new product launches and acquisitions to exploit maximum revenue potential in global chemical peel market.
The veterinary pain management market is segmented by product, application, animal type, distribution channel and geography. On the basis of product, the veterinary pain management market is segmented into drugs and devices. The drugs segment is bifurcated into type and route of administration. Furthermore, type segment is classified into NSAIDS, opioids, local anesthetics, alpha-2 agonists, disease-modifying osteoarthritis drugs (DMOADS) and other drugs. Likewise, the route of administration is segmented into oral, parenteral and topical. Moreover, the devices segment is categorized into laser therapy devices and electromagnetic therapy devices.
Various procedures were studied in the report such as a companion animals and livestock. Among these, the companion animals segment is classified into dogs, cats and horses and other companion animals. Furthermore, livestock segment is bifurcated into cattle, swine and other livestock. The companion animals segment accounted for the largest market share, owing to the increasing companion animal ownership, rising awareness about animal health among pet owners and increasing pet healthcare expenditure.
Based on application, the veterinary pain management market is segmented into joint pain, postoperative pain, cancer, others (traumatic pain, abdominal pain, neuropathic pain, dermatological pain, mastitis etc.). The joint pain segment is classified into osteoarthritis and musculoskeletal disorders. The joint pain application on high demand in veterinary pain management market owing to the rising pet population, increasing prevalence of musculoskeletal disorders.
On the basis of end user, the veterinary pain management market is segmented into veterinary hospitals & clinics, research institutes and universities and laboratories. The hospitals & clinics segment has significant share in the veterinary pain management market and is also estimated to dominate the market during the forecast period 2020 to 2025. Increasing number of hospitals, growing veterinary expenditure and combination treatments are key factors boosting the hospitals segment.
By geography, the veterinary pain management market is studied across the countries of key regions such as, North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America accounted for the largest market share in 2018, followed by Asia-Pacific. Growing animal healthcare expenditure, large number of hospitals & clinics, growing pool of veterinarians, and high prevalence of diseases causing pain in the region. However, the Asia-Pacific region is projected to grow at a fastest CAGR during the forecast period, due to advancement in health care services in veterinary pain management.
Why to buy this report:
